The Clival Chordoma Imaging Best Practices Tips
The Clival Chordoma Imaging Best Practices Tips The Clival chordoma is a rare but challenging tumor arising from remnants of the notochord at the clivus, a skull base region critical for neurovascular structures. Precise imaging plays a pivotal role in diagnosis, surgical planning, and postoperative follow-up. Given the complex anatomy of the skull base, optimizing imaging protocols is essential to accurately delineate tumor extent, assess involvement of adjacent structures, and evaluate recurrence.
Magnetic Resonance Imaging (MRI) remains the gold standard for evaluating clival chordomas. High-resolution, thin-slice MRI sequences provide excellent soft tissue contrast, enabling detailed visualization of the tumor’s extent. T1-weighted images with and without gadolinium contrast are fundamental, as chordomas typically appear hypointense to isointense on T1 and show variable enhancement post-contrast. T2-weighted images are equally important because chordomas often have a characteristic lobulated, high-signal appearance due to their myxoid matrix. Incorporating diffusion-weighted imaging (DWI) can help distinguish residual or recurrent tumor from postoperative changes, although its utility is limited by susceptibility artifacts near the skull base.
Computed Tomography (CT) complements MRI by offering superior assessment of bony involvement. Since clival chordomas tend to erode or destroy the bone, thin-slice, high-resolution CT scans with bone algorithms are recommended. These images reveal the extent of osseous destruction, calcifications within the tumor (which are common), and the involvement of crucial structures like the carotid canal, sphenoid sinus, and clival cortex. Accurate delineation of bony erosion guides surgical approaches and helps in preoperative planning to minimize neurovascular risk.
Optimal imaging requires meticulous technique. For MRI, using a dedicated skull base coil and including sequences such as pre- and post-contrast T1, T2, and DWI improves lesion characterization. The use of 3D sequences, like volumetric T2 or contrast-enhanced T1, facilitates multiplanar reconstructions, aiding surgical

navigation. For CT, thin slices (1 mm or less) with isotropic voxels enable detailed 3D reconstructions and precise assessment of bony anatomy.
Beyond initial diagnosis, serial imaging is crucial for monitoring treatment response and detecting recurrence. Postoperative changes such as gliosis or fibrosis can mimic residual tumor on MRI; thus, the radiologist must compare with preoperative images and consider advanced techniques like magnetic resonance spectroscopy or PET-CT in ambiguous cases.
Finally, collaboration between neuroradiologists, neurosurgeons, and radiation oncologists enhances the interpretation of imaging findings. Clear communication regarding the tumor’s boundaries, involvement of neurovascular structures, and surgical corridors ensures that imaging effectively guides clinical decision-making.
In summary, best practices in clival chordoma imaging involve a comprehensive approach utilizing high-quality MRI with specific sequences, detailed bony assessment with thin-slice CT, and ongoing multidisciplinary review. This integrated strategy improves diagnostic accuracy, optimizes surgical outcomes, and supports effective long-term management of this complex tumor.










